Arrowhead Pharma (ARWR) PT Raised to $99 at Piper Sandler Ahead of Study Initiations
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $99.00 (from $90.00) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
